FDA Investigator: Steven Fong

- Steven Fong first started conducting FDA inspections in 2012, with the last inspection in 2019. Over that time, Steven Fong has conducted 22 inspections at 19 companies across 22 sites.

Documents

FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2018

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Alcami Carolinas Corporation, Charleston | 2018

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Toyobo Co. Ltd., Otsu | 2018

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Alexion Pharma International Operations Unlimited Co., Athlone | 2017

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Merck Serono SA (Vevey), Corsier-sur-Vevey | 2016

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Amgen, Inc., Thousand Oaks | 2016

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Sanofi Winthrop Industrie, Le Trait | 2015

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Immunex Rhode Island Corporation, West Greenwich | 2015

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 GP Grenzach Produktions GmbH, Grenzach Wyhlen | 2014

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 GP Grenzach Produktions GmbH, Grenzach-Wyhlen | 2014

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Amgen Manufacturing Limited, Juncos | 2014

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2013

Out-of-stock
Steven Fong
Human Drug Form 483

FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2013

Out-of-stock
Steven Fong
Human Drug Form 483